← Leaderboards
Fergus Joseph Couch
Mayo Clinic Rochester
$34,303,973
Attributed
$42,282,661
Total exposure
24
Grants
21
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.3M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$46,327,653 · 25
By mechanism
R01$24,493,700 · 7
P50$8,920,981 · 11
R35$4,895,341 · 1
P01$4,044,992 · 2
U01$2,684,558 · 1
U24$987,571 · 1
Top collaborators
- Katherine L Nathanson10 shared
- Saravut Weroha6 shared
- William A Cliby5 shared
- David E. Goldgar4 shared
- Kenneth Offit4 shared
- Amanda Barbara Spurdle3 shared
Most similar at Mayo Clinic Rochester
Same institution · by research overlap
- Saravut Weroha$5,625,190
- Amanda Barbara Spurdle$314,275
- Peter C. Harris$28,592,075
- Shaji Kunnathu Kumar$7,127,192
- Kelsey Stuttgen Finn$1
Others in their field
Top investigators on “Genes”
- David Heimbrook · Leidos Biomedical Research, Inc.$413,811,031
- Richard A Gibbs · Baylor College Of Medicine$338,750,128
- Barton F Haynes · Duke University$304,076,400
- Stacey Gabriel · Massachusetts Institute Of Technology$241,252,013
- Eric S Lander · Whitehead Institute For Biomedical Res$211,825,987
- Richard K. Wilson · Washington University$195,881,965
Research focus
GenesMalignant NeoplasmsCancer RiskRisk AssessmentMalignant Breast NeoplasmBrca1 GeneBaseVariantMutationBrca2 GeneClinicWomanFamilyMalignant Neoplasm Of OvaryGeneticSusceptibility GeneLeadFamily History OfProteinsPredispositionClassificationTumorPathogenicityPrevention
Grant awards (100)
Resolving the cancer relevance of predisposition gene mutations$847,111
R35 · FY2025 · CA · contact PI
Curation Expert Panels for BRCA1/2 and Hereditary Breast, Ovarian and Pancreatic (HBOP) Cancer Genes$359,021
U24 · FY2025 · CA · contact PI
Project 1$267,960
P50 · FY2025 · CA · contact PI
Resolving the cancer relevance of predisposition gene mutations$638,814
R35 · FY2024 · CA · contact PI
Project 1$409,868
P50 · FY2024 · CA · contact PI
The contribution of RAD51C and RAD51D to breast and ovarian cancer$289,844
R01 · FY2024 · CA · contact PI
BRCA1/2 and Hereditary Breast, Ovarian and Pancreatic (HBOP) Cancer Variant Curation Expert Panels$83,063
U24 · FY2024 · CA · contact PI
Career Enhancement Program$68,332
P50 · FY2024 · CA · contact PI
Resolving the cancer relevance of predisposition gene mutations$570,912
R35 · FY2023 · CA · contact PI
Project 1$490,552
P50 · FY2023 · CA · contact PI
BRCA1/2 and Hereditary Breast, Ovarian and Pancreatic (HBOP) Cancer Variant Curation Expert Panels$251,798
U24 · FY2023 · CA · contact PI
Career Enhancement Program$75,076
P50 · FY2023 · CA · contact PI
Resolving the cancer relevance of predisposition gene mutations$933,468
R35 · FY2022 · CA · contact PI
The contribution of RAD51C and RAD51D to breast and ovarian cancer$451,372
R01 · FY2022 · CA · contact PI
Project 1$385,456
P50 · FY2022 · CA · contact PI
BRCA1/2 and Hereditary Breast, Ovarian and Pancreatic (HBOP) Cancer Variant Curation Expert Panels$293,689
U24 · FY2022 · CA · contact PI
Career Enhancement Program$73,772
P50 · FY2022 · CA · contact PI
Resolving the cancer relevance of predisposition gene mutations$952,518
R35 · FY2021 · CA · contact PI
The contribution of RAD51C and RAD51D to breast and ovarian cancer$476,517
R01 · FY2021 · CA · contact PI
01 Project 1: Cancer risks for mutations in breast cancer predisposition genes$80,648
P50 · FY2021 · CA · contact PI
Career Enhancement Program$73,935
P50 · FY2021 · CA · contact PI
Resolving the cancer relevance of predisposition gene mutations$952,518
R35 · FY2020 · CA · contact PI
01 Project 1: Cancer risks for mutations in breast cancer predisposition genes$427,056
P50 · FY2020 · CA · contact PI
The contribution of RAD51C and RAD51D to breast and ovarian cancer$311,277
R01 · FY2020 · CA · contact PI
The contribution of RAD51C and RAD51D to breast and ovarian cancer$499,954
R01 · FY2019 · CA · contact PI
01 Project 1: Cancer risks for mutations in breast cancer predisposition genes$458,126
P50 · FY2019 · CA · contact PI
Risk and penetrance of mutations from breast cancer testing panels.$1,055,961
R01 · FY2018 · CA · contact PI
Identifying and validating novel susceptibility genes for breast cancer$684,391
R01 · FY2018 · CA · contact PI
The contribution of RAD51C and RAD51D to breast and ovarian cancer$511,059
R01 · FY2018 · CA · contact PI
01 Project 1: Cancer risks for mutations in breast cancer predisposition genes$508,510
P50 · FY2018 · CA · contact PI
Targeting DNA Repair in Selected Patients with Pancreatic Cancer: An Approach to$306,478
P50 · FY2018 · CA · contact PI
Risk and penetrance of mutations from breast cancer testing panels.$1,263,145
R01 · FY2017 · CA · contact PI
Identifying and validating novel susceptibility genes for breast cancer$680,501
R01 · FY2017 · CA · contact PI
BRCA1 and BRCA2 missense mutations and breast cancer risk$527,128
U01 · FY2017 · CA · contact PI
01 Project 1: Cancer risks for mutations in breast cancer predisposition genes$494,441
P50 · FY2017 · CA · contact PI
Targeting DNA Repair in Selected Patients with Pancreatic Cancer: An Approach to$269,931
P50 · FY2017 · CA · contact PI
Risk and penetrance of mutations from breast cancer testing panels.$1,299,901
R01 · FY2016 · CA · contact PI
Identifying and validating novel susceptibility genes for breast cancer$675,236
R01 · FY2016 · CA · contact PI
BRCA1 and BRCA2 missense mutations and breast cancer risk$527,128
U01 · FY2016 · CA · contact PI
01 Project 1: Cancer risks for mutations in breast cancer predisposition genes$478,350
P50 · FY2016 · CA · contact PI
Targeting DNA Repair in Selected Patients with Pancreatic Cancer: An Approach to$287,615
P50 · FY2016 · CA · contact PI
Risk and penetrance of mutations from breast cancer testing panels.$1,319,364
R01 · FY2015 · CA · contact PI
Identifying and validating novel susceptibility genes for breast cancer$676,922
R01 · FY2015 · CA · contact PI
BRCA1 and BRCA2 missense mutations and breast cancer risk$527,128
U01 · FY2015 · CA · contact PI
Targeting DNA Repair in Selected Patients with Pancreatic Cancer: An Approach to$291,244
P50 · FY2015 · CA · contact PI
Risk and penetrance of mutations from breast cancer testing panels.$1,408,225
R01 · FY2014 · CA · contact PI
Identifying and validating novel susceptibility genes for breast cancer$704,905
R01 · FY2014 · CA · contact PI
BRCA1 and BRCA2 missense mutations and breast cancer risk$520,019
U01 · FY2014 · CA · contact PI
Targeting DNA Repair in Selected Patients with Pancreatic Cancer: An Approach to$287,535
P50 · FY2014 · CA · contact PI
BRCA1 and BRCA2 missense mutations and breast cancer risk$583,155
U01 · FY2013 · CA · contact PI
Career Development Program$74,332
P50 · FY2013 · CA · contact PI
A genome-wide association study for breast cancer in BRCA1 mutation carriers$667,287
R01 · FY2012 · CA · contact PI
Risk Assessment for Carriers of Variants of Uncertain Significance (VUS)$332,159
P50 · FY2012 · CA · contact PI
Career Development Program$122,401
P50 · FY2012 · CA · contact PI
Career Development Program$67,134
P50 · FY2012 · CA · contact PI
A genome-wide association study for breast cancer in BRCA1 mutation carriers$816,469
R01 · FY2011 · CA · contact PI
BRCA2 missense mutations and breast cancer$512,304
R01 · FY2011 · CA · contact PI
Genetic epidemiology of cell division regulation in breast cancer$505,850
R01 · FY2011 · CA · contact PI
Career Development Program$113,279
P50 · FY2011 · CA · contact PI
Career Development Program$65,176
P50 · FY2011 · CA · contact PI
A genome-wide association study for breast cancer in BRCA1 mutation carriers$1,070,366
R01 · FY2010 · CA · contact PI
Genetic epidemiology of cell division regulation in breast cancer$537,673
R01 · FY2010 · CA · contact PI
BRCA2 missense mutations and breast cancer$528,234
R01 · FY2010 · CA · contact PI
Career Development Program$122,318
P50 · FY2010 · CA · contact PI
Career Development Program$68,733
P50 · FY2010 · CA · contact PI
A genome-wide association study for breast cancer in BRCA1 mutation carriers$1,097,030
R01 · FY2009 · CA · contact PI
Genetic epidemiology of cell division regulation in breast cancer$548,954
R01 · FY2009 · CA · contact PI
BRCA2 missense mutations and breast cancer$517,966
R01 · FY2009 · CA · contact PI
BRCA2 Missense Mutations and Breast Cancer$331,977
P50 · FY2009 · CA · contact PI
BRCA2 missense mutations and breast cancer$302,191
R01 · FY2009 · CA · contact PI
Genetic epidemiology of cell division regulation in breast cancer$301,942
R01 · FY2009 · CA · contact PI
Career Development Program$126,170
P50 · FY2009 · CA · contact PI
Career Development Program$68,811
P50 · FY2009 · CA · contact PI
A genome-wide association study for breast cancer in BRCA1 mutation carriers$1,137,311
R01 · FY2008 · CA · contact PI
Genetic epidemiology of cell division regulation in breast cancer$542,988
R01 · FY2008 · CA · contact PI
BRCA2 missense mutations and breast cancer$526,502
R01 · FY2008 · CA · contact PI
BRCA2 Missense Mutations and Breast Cancer$253,546
P50 · FY2008 · CA · contact PI
Career Development Program$92,556
P50 · FY2008 · CA · contact PI
BRCA2 missense mutations and breast cancer$573,091
R01 · FY2007 · CA · contact PI
Genetic epidemiology of cell division regulation in breast cancer$558,963
R01 · FY2007 · CA · contact PI
P-2: BRCA2 Missense Mutations and Breast Cancer$350,064
P50 · FY2007 · CA · contact PI
Developmental Research Program$185,780
P50 · FY2007 · CA · contact PI
Characterization of the Chromosome 17q23 Amplicon$282,561
R01 · FY2006 · CA · contact PI
P-2: BRCA2 Missense Mutations and Breast Cancer$272,221
P50 · FY2006 · CA · contact PI
Developmental Research Program$139,572
P50 · FY2006 · CA · contact PI
Characterization of the Chromosome 17q23 Amplicon$289,361
R01 · FY2005 · CA
P-2: BRCA2 Missense Mutations and Breast Cancer$264,359
P50 · FY2005 · CA
Developmental Research Program$135,508
P50 · FY2005 · CA
EPIDEMIOLOGIC AND GENETIC STUDIES OF BREAST CANCER$1,925,961
P01 · FY2004 · CA
Characterization of the Chromosome 17q23 Amplicon$289,361
R01 · FY2004 · CA
EPIDEMIOLOGIC AND GENETIC STUDIES OF BREAST CANCER$2,119,031
P01 · FY2003 · CA
Characterization of the Chromosome 17q23 Amplicon$289,361
R01 · FY2003 · CA
Characterization of the role of BRCA2 in pancreatic cancer$0
P20 · FY2003 · CA
Characterization of the Chromosome 17q23 Amplicon$289,361
R01 · FY2002 · CA
P21 INDUCTION BY BRCA2$100,170
R29 · FY2002 · CA
INTERACTION OF NONGENETIC RISK FACTORS WITH BRCA1$0
P01 · FY2002 · CA
P21 INDUCTION BY BRCA2$100,170
R29 · FY2001 · CA
INTERACTION OF NONGENETIC RISK FACTORS WITH BRCA1$0
P01 · FY2001 · CA
P21 INDUCTION BY BRCA2$100,170
R29 · FY2000 · CA
INTERACTION OF NONGENETIC RISK FACTORS WITH BRCA1$0
P01 · FY2000 · CA